|
2017 Journal Article Vascular complications in diabetes: old messages, new thoughtsForbes, Josephine M. and Fotheringham, Amelia K. (2017). Vascular complications in diabetes: old messages, new thoughts. Diabetologia, 60 (11), 2129-2138. doi: 10.1007/s00125-017-4360-x |
|
2017 Journal Article Serum 25-hydroxyvitamin D concentrations are associated with nuclear factor kappa-B activity but not with inflammatory markers in healthy normoglycemic adultsMousa, Aya, de Courten, Maximilian P. J., Forbes, Josephine and de Courten, Barbora (2017). Serum 25-hydroxyvitamin D concentrations are associated with nuclear factor kappa-B activity but not with inflammatory markers in healthy normoglycemic adults. Journal of Steroid Biochemistry and Molecular Biology, 177, 216-222. doi: 10.1016/j.jsbmb.2017.07.013 |
|
2017 Journal Article Effect of dietary advanced glycation end products on inflammation and cardiovascular risks in healthy overweight adults: a randomised crossover trialBaye, Estifanos, de Courten, Maximilian P. J., Walker, Karen, Ranasinha, Sanjeeva, Earnest, Arul, Forbes, Josephine M. and de Courten, Barbora (2017). Effect of dietary advanced glycation end products on inflammation and cardiovascular risks in healthy overweight adults: a randomised crossover trial. Scientific Reports, 7 (1) 4123, 4123. doi: 10.1038/s41598-017-04214-6 |
|
2017 Journal Article Disparity in the micronutrient content of diets high or low in advanced glycation end products (AGEs) does not explain changes in insulin sensitivityPearce, Karma, Hatzinikolas, Alicia, Moran, Lisa, de Courten, Maximilian P. J., Forbes, Josephine, Scheijen, Jean L. J. M., Schalkwijk, Casper G., Walker, Karen and de Courten, Barbora (2017). Disparity in the micronutrient content of diets high or low in advanced glycation end products (AGEs) does not explain changes in insulin sensitivity. International Journal of Food Sciences and Nutrition, 68 (8), 1-6. doi: 10.1080/09637486.2017.1319468 |
|
2017 Journal Article A drop in the circulating concentrations of soluble receptor for advanced glycation end products is associated with seroconversion to autoantibody positivity but not with subsequent progression to clinical disease in children en route to type 1 diabetesSalonen, K. M., Ryhanen, S. J., Forbes, J. M., Harkonen, T., Ilonen, J., Simell, O., Veijola, R., Groop, P. -H. and Knip, M. (2017). A drop in the circulating concentrations of soluble receptor for advanced glycation end products is associated with seroconversion to autoantibody positivity but not with subsequent progression to clinical disease in children en route to type 1 diabetes. Diabetes/Metabolism Research and Reviews, 33 (4) e2872, e2872. doi: 10.1002/dmrr.2872 |
|
2017 Conference Publication Mitochondrial dysfunction defines a population of young people with type 1 diabetes at risk of kidney diseaseForbes, J. M., Flemming, N. B., Mccarthy, D. A., Boot, K., De Silva, N., Gallo, L. A., Nisbett, J., Morton, A., Teasdale, S., Thorburn, D. R., Russell, A., Isbel, N., Johnson, D., Morahan, G., Jones, T., Couper, J., Donaghue, K., Hodson, M. P. and O'Moore-Sullivan, T. (2017). Mitochondrial dysfunction defines a population of young people with type 1 diabetes at risk of kidney disease. 53rd Annual Meeting of the European Association for the Study of Diabetes (EASD), Lisbon, Portugal, 11-15 September 2017. Richmond, VIC, Australia: Wiley-Blackwell Publishing Asia. |
|
2017 Conference Publication Mitochondrial dysfunction defines a population of young people with type 1 diabetes at risk of kidney diseaseForbes, J. M., Flemming, N., McCarthy, D., Boot, K., D'Silva, N., Gallo, L., Thorburn, D. R., Russell, A., Johnson, D., Morahan, G., Jones, T., Couper, J., Donaghue, K., Hodson, M. and O'Moore-Sullivan, T. (2017). Mitochondrial dysfunction defines a population of young people with type 1 diabetes at risk of kidney disease. 53rd Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD), Lisbon Portugal, 11-15 September 2017. New York NY United States: Springer. |
|
2016 Journal Article Receptor for advanced glycation end products (RAGE) in type 1 diabetes pathogenesisLeung, Sherman S., Forbes, Josephine M. and Borg, Danielle J. (2016). Receptor for advanced glycation end products (RAGE) in type 1 diabetes pathogenesis. Current Diabetes Reports, 16 (10) 100, 100. doi: 10.1007/s11892-016-0782-y |
|
2016 Journal Article Dietary advanced glycation end-products aggravate non-alcoholic fatty liver diseaseLeung, Christopher, Herath, Chandana B., Jia, Zhiyuan, Andrikopoulos, Sof, Brown, Bronwyn E., Davies, Michael J., Rivera, Leni R., Furness, John B., Forbes, Josephine M. and Angus, Peter W. (2016). Dietary advanced glycation end-products aggravate non-alcoholic fatty liver disease. World Journal of Gastroenterology, 22 (35), 8026-8040. doi: 10.3748/wjg.v22.i35.8026 |
|
2016 Conference Publication Understanding Novel Genetic Factors Underlying Circulating Cystatin C and Kidney FunctionFotheringham, A., Balmer, L., Morahan, G. and Forbes, J. (2016). Understanding Novel Genetic Factors Underlying Circulating Cystatin C and Kidney Function. HOBOKEN: WILEY-BLACKWELL. |
|
2016 Journal Article Diabetic kidney disease: a role for advanced glycation end-product receptor 1 (AGE-R1)?Zhuang, Aowen and Forbes, Josephine M. (2016). Diabetic kidney disease: a role for advanced glycation end-product receptor 1 (AGE-R1)?. Glycoconjugate Journal, 33 (4), 645-652. doi: 10.1007/s10719-016-9693-z |
|
2016 Journal Article Targeting advanced glycation with pharmaceutical agents: where are we now?Borg, Danielle J. and Forbes, Josephine M. (2016). Targeting advanced glycation with pharmaceutical agents: where are we now?. Glycoconjugate Journal, 33 (4), 653-670. doi: 10.1007/s10719-016-9691-1 |
|
2016 Journal Article Mitochondria-power players in kidney function?Forbes, Josephine M. (2016). Mitochondria-power players in kidney function?. Trends in Endocrinology and Metabolism, 27 (7), 441-442. doi: 10.1016/j.tem.2016.05.002 |
|
2016 Conference Publication Reduced Insulin Sensitivity Is Associated with Increased Glomerular Filtration Rate in Healthy Nondiabetic Individuals, Independent of Body Mass Index, Adiposity, and Blood PressureNaderpoor, Negar, Lyons, Jasmine G., Soldatos, Georgia, Mousa, Aya, Forbes, Josephine M. and De Courten, Barbora (2016). Reduced Insulin Sensitivity Is Associated with Increased Glomerular Filtration Rate in Healthy Nondiabetic Individuals, Independent of Body Mass Index, Adiposity, and Blood Pressure. 76th Scientific Sessions of the American-Diabetes-Association, New Orleans La, Jun 10-14, 2016. ALEXANDRIA: AMER DIABETES ASSOC. |
|
2016 Journal Article Diet low in advanced glycation end products increases insulin sensitivity in healthy overweight individuals: a double-blind, randomized, crossover trialde Courten, Barbora, de Courten, Maximilian P. J., Soldatos, Georgia, Dougherty, Sonia L., Straznicky, Nora, Schlaich, Markus, Sourris, Karly C., Chand, Vibhasha, Scheijen, Jean L. J. M., Kingwell, Bronwyn A., Cooper, Mark E., Schalkwijk, Casper G., Walker, Karen Z. and Forbes, Josephine M. (2016). Diet low in advanced glycation end products increases insulin sensitivity in healthy overweight individuals: a double-blind, randomized, crossover trial. American Journal of Clinical Nutrition, 103 (6), 1426-1433. doi: 10.3945/ajcn.115.125427 |
|
2016 Journal Article Once daily administration of the SGLT2 inhibitor, empagliflozin, attenuates markers of renal fibrosis without improving albuminuria in diabetic db/db miceGallo, Linda A., Ward, Micheal S., Fotheringham, Amelia K., Zhuang, Aowen, Borg, Danielle J., Flemming, Nicole B., Harvie, Ben M., Kinneally, Toni L., Yeh, Shang-Ming, McCarthy, Domenica A., Koepsell, Hermann, Vallon, Volker, Pollock, Carol, Panchapakesan, Usha and Forbes, Josephine M. (2016). Once daily administration of the SGLT2 inhibitor, empagliflozin, attenuates markers of renal fibrosis without improving albuminuria in diabetic db/db mice. Scientific Reports, 6 (1) 26428, 28124. doi: 10.1038/srep26428 |
|
2016 Journal Article Antigen-encoding bone marrow terminates islet-directed memory CD8+ T-cell responses to alleviate islet transplant rejectionColeman, Miranda A., Jessup, Claire F., Bridge, Jennifer A., Overgaard, Nana H., Penko, Daniella, Walters, Stacey, Borg, Danielle J., Galea, Ryan, Forbes, Josephine M., Thomas, Ranjeny, Coates, Patrick T. C., Grey, Shane T., Wells, James W. and Steptoe, Raymond J. (2016). Antigen-encoding bone marrow terminates islet-directed memory CD8+ T-cell responses to alleviate islet transplant rejection. Diabetes, 65 (5), 1328-1340. doi: 10.2337/db15-1418 |
|
2016 Journal Article Deficiency in apoptosis-inducing factor recapitulates chronic kidney disease via aberrant mitochondrial homeostasisCoughlan, Melinda T., Higgins, Gavin C., Tuong-Vi Nguyen, Penfold, Sally A., Thallas-Bonke, Vicki, Tan, Sih Mm, Ramm, Georg, Van Bergen, Nicole J., Henstridge, Darren C., Sourris, Karly C., Harcourt, Brooke E., Trounce, Ian A., Robb, Portia M., Laskowski, Adrienne, McGee, Sean L., Genders, Amanda J., Walder, Ken, Drew, Brian G., Gregorevic, Paul, Qian, Hongwei, Thomas, Merlin C., Jerums, George, Macisaac, Richard J., Skene, Alison, Ekinci, Elif I., Wijeyeratne, Xiaonan W., Gallo, Linda A., Heiman-Edelstein, Michal, Ryan, Michael T. ... Forbes, Josephine M. (2016). Deficiency in apoptosis-inducing factor recapitulates chronic kidney disease via aberrant mitochondrial homeostasis. Diabetes, 65 (4), 1085-1098. doi: 10.2337/db15-0864 |
|
2016 Conference Publication The SGLT2 Inhibitor, Empagliflozin, Attenuates Some Markers of Renal Fibrosis without Improving Albuminuria in Diabetic Db/Db MiceGallo, Linda A., Ward, Micheal S., Fotheringham, Amelia K., Zhuang, Aowen, Koepsell, Hermann, Vallon, Volker, Pollock, Carol, Panchapakesan, Usha and Forbes, Josephine M. (2016). The SGLT2 Inhibitor, Empagliflozin, Attenuates Some Markers of Renal Fibrosis without Improving Albuminuria in Diabetic Db/Db Mice. Experimental Biology 2016 Meeting, San Diego, CA United States, 1-5 April 2016. Hoboken, NJ United States: John Wiley & Sons. doi: 10.1096/fasebj.30.1_supplement.740.18 |
|
2016 Conference Publication The SGLT2 Inhibitor, Empagliflozin, Attenuates Some Markers of Renal Fibrosis without Improving Albuminuria in Diabetic <i>Db</i>/<i>Db</i> MiceGallo, Linda A., Ward, Micheal S., Fotheringham, Amelia K., Zhuang, Aowen, Koepsell, Hermann, Vallon', Volker, Pollock, Carol, Panchapakesan, Usha and Forbes, Josephine M. (2016). The SGLT2 Inhibitor, Empagliflozin, Attenuates Some Markers of Renal Fibrosis without Improving Albuminuria in Diabetic Db/Db Mice. Experimental Biology Meeting, San Diego Ca, Apr 02-06, 2016. BETHESDA: FEDERATION AMER SOC EXP BIOL. |
